Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Biomedicines|July 27, 2024
Sympathetic Activation Promotes Sodium Glucose Co-Transporter-1 Protein Expression in Rodent Skeletal MuscleJennifer R Matthews, Lakshini Y Herat, Markus P Schlaich, et al.
Current Hypertension Reports|March 2, 2022
Targeting Features of the Metabolic Syndrome Through Sympatholytic Effects of SGLT2 InhibitionLakshini Y Herat, Jennifer Matthews, Omar Azzam, et al.
International Journal of Endocrinology|August 21, 2018
Focusing on Sodium Glucose Cotransporter-2 and the Sympathetic Nervous System: Potential Impact in Diabetic RetinopathyLakshini Y Herat, Vance B Matthews, P Elizabeth Rakoczy, et al.
Biomedicines|March 16, 2019
Current Knowledge of IL-6 Cytokine Family Members in Acute and Chronic Kidney DiseaseAaron L Magno, Lakshini Y Herat, Revathy Carnagarin, et al.
Current Diabetes Reports|September 21, 2018
Autonomic Regulation of Glucose Homeostasis: a Specific Role for Sympathetic Nervous System ActivationRevathy Carnagarin, Vance B Matthews, Lakshini Y Herat, et al.
Frontiers in Bioscience (Landmark Edition)|April 28, 2023
Comparing and Contrasting the Effects of the SGLT Inhibitors Canagliflozin and Empagliflozin on the Progression of RetinopathyLakshini Y Herat, Jennifer R Matthews, Elizabeth P Rakoczy, et al.
Biomedicines|November 21, 2020
SGLT2 Inhibitor-Induced Sympathoexcitation in White Adipose Tissue: A Novel Mechanism for BeigingJennifer R Matthews, Lakshini Y Herat, Aaron L Magno, et al.
Expert Opinion on Pharmacotherapy|April 18, 2020
An evaluation of empagliflozin and it's applicability to hypertension as a therapeutic optionLakshini Y Herat, Vance B Matthews, Aaron L Magno, et al.
Journal of Clinical Medicine|August 30, 2020
The Influence of Hypertensive Therapies on Circulating Factors: Clinical Implications for SCFAs, FGF21, TNFSF14 and TNF-αAaron L Magno, Lakshini Y Herat, Márcio G Kiuchi, et al.
Frontiers in Bioscience (Landmark Edition)|January 10, 2023
Determining the Role of SGLT2 Inhibition with Dapagliflozin in the Development of Diabetic RetinopathyLakshini Y Herat, Jennifer R Matthews, Wei E Ong, et al.
Pageof 3